Oct 15, 2024, 10:33
Elisabetta Bonzano: Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:
” Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials – The Lancet
After adjustment, women diagnosed since 2000 have about a fifth lower rate of distant recurrence than the 1990s.
Trial outcomes have improved over time in both HR+ and HR- cancers.
Most (80–90%) of this improvement can be explained by a combination of two factors: greater recruitment of women at lower risk in modern trials; and improved adjuvant therapies.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 4, 2025, 03:12
Sep 4, 2025, 03:01
Sep 4, 2025, 00:02
Sep 3, 2025, 22:35
Sep 3, 2025, 22:09